by Jason Heaviland | Oct 1, 2026
Why Has Genomics Not Solved Most Chronic Diseases? Why hasn’t genomics solved most chronic diseases? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains why genomics has provided valuable insights into health and disease, but cannot capture every factor...
by Jason Heaviland | Sep 29, 2026
How Is Multi-Omics Changing Chronic Disease Diagnosis? How is multi-omics changing the way researchers define and diagnose chronic disease? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains how combining molecular data can provide greater resolution...
by Jason Heaviland | Sep 28, 2026
What Is the Biggest Challenge in Integrating Multi-Omics Data? How can researchers make complex multi-omics datasets work together? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains the challenges of integrating genomics, proteomics, metabolomics, and...
by Jason Heaviland | Apr 21, 2026
Decoding Alzheimer’s Disease with Multi-Omics Alzheimer’s disease involves coordinated changes across metabolism, proteins and cellular systems. By combining metabolomics and proteomics, this study examines how these changes relate within the same biological...
by Jason Heaviland | Apr 20, 2026 | Uncategorized
Alzheimer’s as a System-Level Disorder via Multi-Omics Alzheimer’s disease is not driven by a single pathway, molecule or mutation. Instead, it reflects a system-level breakdown across metabolism, protein regulation and cellular signaling. Yet most studies still...
